| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |